Abstract:Background: Many anticancer agents have poor water solubility and therefore the development of novel delivery systems for such molecules has received significant attention. Nanocarriers show great potential in delivering therapeutic agents into the targeted organs or cells and have recently emerged as a promising approach to cancer treatments. The aim of this study was to prepare and use poly-2-hydroxyethyl methacrylate (PHEMA) nanoparticles for the controlled release of the anticancer drug doxorubicin.
“…The amount of INN released increases with increasing percent loading. Similar results were reported previously by us and others for different drug-release system [27][28][29].…”
Section: Effect Of % Loading On Drug Releasesupporting
Hyperbranched poly(3-ethyl-3-(hydroxymethyl)oxetane) (HPBO), modified by S-1-dodecyl-S -(α,α -dimethyl-α -acetic acid) trithiocarbonate (DMP) to form a RAFT macroinitiator, and then two monomers, 2-(dimethylamino)ethyl-methacrylate (DMAEMA) and acrylic acid (AA), were polymerized to obtain novel pH-and thermo-sensitive polymers with a hyperbranched polymer core. These polymers exhibited phase transitions in response to pH and temperature. They were possible to harvest a bioactive molecule, indometacin, from solution using the phase transition of these pH-and thermo-sensitive polymers. Various parameters, such as percent loading of drugs, pH, temperature and nature of the release media on the release profiles, were investigated. The resultant polymer carriers can potentially be used for the controlled release of the anti-inflammatory drug indometacin.
“…The amount of INN released increases with increasing percent loading. Similar results were reported previously by us and others for different drug-release system [27][28][29].…”
Section: Effect Of % Loading On Drug Releasesupporting
Hyperbranched poly(3-ethyl-3-(hydroxymethyl)oxetane) (HPBO), modified by S-1-dodecyl-S -(α,α -dimethyl-α -acetic acid) trithiocarbonate (DMP) to form a RAFT macroinitiator, and then two monomers, 2-(dimethylamino)ethyl-methacrylate (DMAEMA) and acrylic acid (AA), were polymerized to obtain novel pH-and thermo-sensitive polymers with a hyperbranched polymer core. These polymers exhibited phase transitions in response to pH and temperature. They were possible to harvest a bioactive molecule, indometacin, from solution using the phase transition of these pH-and thermo-sensitive polymers. Various parameters, such as percent loading of drugs, pH, temperature and nature of the release media on the release profiles, were investigated. The resultant polymer carriers can potentially be used for the controlled release of the anti-inflammatory drug indometacin.
“…21 Spectrum band 5 of SPC-CHL-PE-DOX appeared stronger in comparison to that of SPC-CHL-DOX. The peak was indicative of the presence of SPC in the mixture.…”
Introduction: Phosphatidylethanolamine (PE)-conjugated nanoliposomes were developed, characterized, and investigated for their accumulation in liver, kidneys, and lungs in rats. Methods: Drug-excipient interaction was studied using Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), surface morphology by field emission scanning electron microscopy, elemental analysis by energy dispersive X-ray (EDX) analysis, zeta potential and size distribution using a Zetasizer and particle size analyzer, and in vitro drug release by dialysis membrane. In vivo accumulation of liposomes in tissues was also studied. Results: No chemical reaction was observed between drug and excipients. EDX study confirmed PE-conjugation in liposomes. Doxorubicin-loaded liposomes (DOX-L) and PE-conjugated doxorubicin-loaded liposomes (DOX-PEL) were of smooth surface and homogenously distributed in nanosize range (32-37 nm) with a negative surface charge. Loading efficiencies were 49.25% ± 1.05% and 52.98% ± 3.22% respectively, for DOX-L and DOX-PEL. In vitro drug release study showed 69.91% ± 1.05% and 77.07% ± 1.02% doxorubicin released, from DOX-L and DOX-PEL, respectively, in nine hours. Fluorescence microscopic study showed that liposomes were well distributed in liver, lungs, and kidneys. Conclusion: Data suggests that PE-conjugated nanoliposomes released the drug in a sustained manner and were capable of distributing them in various organs. This may be used for cell/ tissue targeting, attaching specific antibodies to PE.
“…The negative potentials of nGO flakes decreased upon DOX incorporation because DOX passivates the oxygen-containing functional groups on the nGO flakes; furthermore, the amine groups in DOX may neutralize the negative charges on nGO surfaces (Supplementary Figure S4B). 34 cPEG incorporation further changed the zeta potential of nGO@DOX flakes to positive polarity, which may be due to the additional incorporation of amine groups from the chitosan matrix. 35 The effects of cPEG incorporation on the EE and LC of DOX were also evaluated (Supplementary Figure S4C).…”
Near-infrared (NIR)-induced chemothermal doxorubicin (DOX) release for anticancer activity was demonstrated using DOX-incorporated fully lateral nanodimensional graphene oxide (nGO) flakes layered with chitosan-polyethylene glycol (PEG) conjugate (nGO@DOX-cPEG) from a single-pass gas-phase self-assembly. Unlike most previously reported graphene oxide-based drug carriers, the proposed processing method introduced a fully nanoscale (both in lateral dimension and thickness) configuration without multistep wet physicochemical processes that enhance the drug-loading capacity and NIR-induced heat generation resulting from the increased surface area. The accumulation of nGO@DOX-cPEG flakes in prostate cancer cells enhanced apoptotic phenomena via the combined effects of DOX release and heat generation upon NIR irradiation. The combined anticancer effects were verified through in vivo assessment with better safety profiles than free DOX. The proposed strategy warrants continuous assembly of multimodal nanocarriers for the efficient treatment of prostate cancers and may be a promising candidate for advanced drug delivery systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.